| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 40.3943 | 8 |
| GSM780708 | Untreated after 4 days (C2_1) | 46.3199 | 34 |
| GSM780709 | Untreated after 4 days (C3_1) | 47.35 | 38 |
| GSM780719 | Untreated after 4 days (C1_2) | 46.7281 | 35 |
| GSM780720 | Untreated after 4 days (C2_2) | 44.5839 | 25 |
| GSM780721 | Untreated after 4 days (C3_2) | 46.6285 | 35 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 43.011 | 17 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 40.1585 | 7 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 43.6996 | 21 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 41.9619 | 13 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 43.1196 | 18 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 42.9051 | 17 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 43.0065 | 17 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 46.2893 | 33 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 41.8892 | 13 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 39.3739 | 5 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 44.7874 | 26 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 46.5374 | 35 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 41.8967 | 13 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 44.5473 | 25 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 38.8687 | 4 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 47.421 | 39 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 41.3704 | 11 |